Rates of hypermethylation of RASSF1A, APC, BVES, TIMP3, GSTP1, and HOXA9 promoters in HCC patients, LC patients, CHB patients, and healthy individuals are shown in Table 2. This evidence concerns the gene APC and hepatocellular carcinoma.